This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Centene Q3 Earnings Beat on Growth in Marketplace Business Line
by Zacks Equity Research
CNC's Q3 results benefit from growth in premiums, driven by strong product positioning. Despite higher revenues, declines in Medicaid membership and increased expenses weigh on profitability.
Universal Health Q3 Earnings Miss on Elevated Operating Costs
by Zacks Equity Research
UHS' Q3 results suffer from rising operating costs in salaries, wages and benefits, and supplies, impacting profitability. Nevertheless, strong revenue growth and increased admissions partly offset the downside.
HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View
by Zacks Equity Research
HCA's quarterly results benefit from improved admissions and inpatient surgeries, partially offset by the impact of hurricanes and rising salaries and benefits expenses.
The Zacks Analyst Blog Highlights Alphabet, UnitedHealth, Chubb, Key Tronic and Massimo
by Zacks Equity Research
Alphabet, UnitedHealth, Chubb, Key Tronic and Massimo are included in this Analyst Blog.
Top Research Reports for Alphabet, UnitedHealth & Chubb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH) and Chubb Limited (CB), as well as two micro-cap stocks Key Tronic Corporation (KTCC) and Massimo Group (MAMO).
Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums
by Zacks Equity Research
MOH's third-quarter results benefit from growing membership and rising premiums, partially offset by rising expenses.
Community Health Q3 Earnings Miss on Lower Adjusted Admissions
by Zacks Equity Research
CYH's third-quarter earnings suffer a setback due to lower admissions and patient days. Improved occupancy levels and reimbursement rates partially offset the negatives.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Beyond UnitedHealth's Q3 Earnings: Time to Reevaluate & Sell Stock?
by Kaibalya Pravo Dey
Looking ahead to 2025, UNH projects adjusted earnings to reach around $30 per share at the top end, which falls short of the Zacks Consensus Estimate.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Molina Healthcare
by Zacks Equity Research
UnitedHealth, The Cigna, Humana and Molina Healthcare are part of the Zacks Industry Outlook article.
Elevance Health's Q3 Earnings Miss Due to Medicaid Redeterminations
by Zacks Equity Research
ELV's third-quarter earnings are hurt by declining membership in Medicaid and Medicare, partially offset by improved product revenues.
4 HMO Stocks to Watch Despite Continued Industry Headwinds
by Zacks Equity Research
The Medical-HMO industry is aided by rising health insurance premiums and strategic M&A moves, but faces margin pressure from high-tech costs and staffing shortages. UNH, CI, HUM and MOH are likely to navigate industry storms.
Brokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UnitedHealth Q3 Earnings Beat on Domestic Commercial Business
by Zacks Equity Research
UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated operating expense level.
Compared to Estimates, UnitedHealth (UNH) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 1.85% and 1.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Q3 Earnings Results of U.S. Corporate Giants in Focus
by Zacks Equity Research
Q3 Earnings Results of U.S. Corporate Giants in Focus.
Bank Holiday Ahead of Busy Stock Trading Week
by Mark Vickery
Despite today's day off from econ metrics, we see a pretty busy week ahead.
Should Invesco S&P 500 Revenue ETF (RWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RWL
Unlocking Q3 Potential of UnitedHealth (UNH): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA
UnitedHealth Pre-Q3 Earnings: Golden Opportunity or Fool's Gold?
by Kaibalya Pravo Dey
UNH's third-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market
by Zacks Equity Research
In the most recent trading session, UnitedHealth Group (UNH) closed at $583.56, indicating a -1.29% shift from the previous trading day.